RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML)
Clinical trials for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML) trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemia: experimental drug CT1390B enters human testing
Disease control Not yet recruitingThis early-stage study tests a new drug called CT1390B in 18 adults aged 18-70 with acute myeloid leukemia that has come back or not responded to standard treatment. The main goals are to check safety, find the right dose, and see if the drug can shrink the cancer. Participants m…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML)
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New hope for tough leukemia? early trial of CT0991 begins
Disease control Not yet recruitingThis early-phase study tests a new drug, CT0991, in 24 adults aged 18-75 with acute myeloid leukemia that has come back or not responded to treatment. The main goals are to find a safe dose and check for side effects. Researchers will also see if the drug can help control the leu…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML)
Phase: PHASE1 • Sponsor: MEI HENG • Aim: Disease control
Last updated May 26, 2026 12:02 UTC